Placeholder Banner

BIO Statement on U.S.-China Comprehensive Economic Dialogue

May 12, 2017

“The Biotechnology Innovation Organization welcomes news of the U.S.-China agreement on initial results of the 100-day Action Plan of the U.S.-China Comprehensive Economic Dialogue,” said Joseph Damond, Executive Vice President for International Affairs.  “The agreement marks an important first step in the 100-day plan and towards broader engagement through the newly formed U.S.-China Comprehensive Economic Dialogue.” 

“Considering the history of this issue, the ultimate test of success will be for China to follow its process and quickly approve the eight pending biotechnology applications and establish a synchronized, timely and predictable process going forward,” added Damond.  “BIO will continue to engage through this process to monitor the implementation of the agreement.”  

Discover More
Washington, D.C. (February 2, 2026) -- The Biotechnology Innovation Organization (BIO) today named Joe Franklin, JD, PhD, as its new chief legal and policy officer. Franklin brings deep expertise in the biomedical sector across law, policy, AI, and…
WASHINGTON, DC (January 7th, 2026) – Today, the Biotechnology Innovation Organization (BIO) announced the launch of the BIO Investment Council (BIC). The newly established council aims to serve small and emerging biotech innovators by increasing…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO)  released the following statement on changes announced to the US childhood vaccine schedule.“American health is as unique as America itself…